CarMax's Spring 2024 Electric Vehicle Consumer Report has revealed that
Tesla has launched the new Model 3 Performance, the quickest, most powerful Model 3 variant ever.
Tesla on Saturday once again cut prices on several of its models for the U.S. market, as part of around-the-world price cuts. Given the cuts, anyone considering the Model 3 and Model Y in the U.S. may want to take a fresh look at the numbers. The base price of the Model Y rear-wheel drive has dropped $2,000 versus last week, to $44,630, while the
Tesla's strategic direction hasn't been received well by investors and the stock is on extended downtrend now. read more
Tesla has launched the performance model for it's revamped 2nd Gen Model 3.
If you’re in the market for an electric vehicle buying a Tesla will now be a little less expensive.
The Tesla Model 3 Performance EV is a testament to the company’s unwavering commitment to pushing the boundaries of electric vehicle technology and design. This groundbreaking model incorporates a host of advanced features and innovations that set it apart from its predecessors and competitors alike. From its innovative Noise, Vibration, and Harshness (NVH) improvements to […]
The new EV is priced starting at $52,990 and is available for pre-orders.
Tesla has accidentally leaked numerous details about upcoming Model 3 Performance "Ludicrous" car.
Live Nation and Ticketmaster have faced widespread public scrutiny for dominance in the ticketing industry, which critics say has allowed them to raise prices on live entertainment.
Live Nation and Ticketmaster have faced widespread public scrutiny for dominance in the ticketing industry, which critics say has allowed them to raise prices on live entertainment.
Federal prosecutors looking at relationship with Purdue Pharma and other drug manufacturers, and its role in US opioid crisisMcKinsey is under criminal investigation in the United States over allegations that the consulting firm played a key role in fueling the opioid epidemic, with federal prosecutors homing in on its work advising OxyContin maker Purdue Pharma and other drugmakers, three people familiar with the matter said.The consulting firm and the US justice department declined to comment....